On Tuesday, Shares of Lululemon Athletica Inc. (NASDAQ:LULU), gained 10.97% to $68.27.
lululemon athletic, declared that the Company will be presenting at the Jefferies 2015 Consumer Conference held at the White Elephant in Nantucket, Massachusetts on Tuesday, June 23, 2015 at 9:00 am Eastern Daylight Time. Stuart Haselden, Chief Financial Officer will host the presentation.
lululemon athletica inc., together with its auxiliaries, designs, manufactures, and distributes athletic apparel and accessories for women, men, and female youth. It operates through two segments, Corporate-Owned Stores and Direct To Consumer.
Shares of Noble Corporation plc (NYSE:NE), declined -0.47% to $16.85, during its last trading session, despite oil prices gained Tuesday on expectations of a sixth straight weekly decline in U.S. crude supplies and a weaker dollar.
Light, sweet crude for July delivery settled up $2, or 3.4%, at $60.14 a barrel on the New York Mercantile Exchange. Brent, the global benchmark, rose $2.19, or 3.5%, to $64.88 a barrel on ICE Futures Europe, according to WSJ.com.
Noble Corporation plc operates as an offshore drilling contractor for the oil and gas industry worldwide. It owns and operates a fleet of mobile offshore drilling units. As of December 31, 2014, the company operated a fleet of 15 jackups, 9 drillships, and 8 semisubmersibles, counting 1 high-specification, harsh environment jackup under construction. Noble Corporation plc was founded in 1921 and is headquartered in London, United Kingdom.
Finally, Vical Incorporated (NASDAQ:VICL), ended its last trade with 22.55% surge, and closed at $1.25, after the biopharmaceutical company had coverage initiated with a “buy” rating by analysts at Roth Capital.
The San Diego-based company also received a $4.65 price target which represents a potential upside of 355% from the stock’s current price.
The firm is very optimistic about the treatments presently being developed in the company’s pipeline, which the firm says presents an opportunity for rapid growth.
During Tuesday’s trade, 4,507,518 shares exchanged hands as compared to its average daily volume of 447,070. The company holds the market capitalization of $114.30M.
Vical Incorporated engages in the research and development of biopharmaceutical products based on its DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.